These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6553501)
1. Characterization of the procoagulant chain derived from human high molecular weight kininogen (Fitzgerald factor) by human tissue kallikrein. Maier M; Austen KF; Spragg J Blood; 1983 Aug; 62(2):457-63. PubMed ID: 6553501 [TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens. Maier M; Austen KF; Spragg J Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386 [TBL] [Abstract][Full Text] [Related]
3. Purification of single-chain human low-molecular-weight kininogen and demonstration of its cleavage by human urinary kallikrein. Maier M; Austen KF; Spragg J Anal Biochem; 1983 Oct; 134(2):336-46. PubMed ID: 6557772 [TBL] [Abstract][Full Text] [Related]
4. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Reddigari S; Kaplan AP Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949 [TBL] [Abstract][Full Text] [Related]
5. Relation between structure and correcting activity of bovine high molecular weight kininogen upon the clotting time of Fitzgerald-trait plasma. Scicli AG; Waldmann R; Guimaraes JA; Scicli G; Carretero OA; Kato H; Han YN; Iwanaga S J Exp Med; 1979 Apr; 149(4):847-55. PubMed ID: 429963 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of human high molecular weight kininogen by human mast cell tryptase. Maier M; Spragg J; Schwartz LB J Immunol; 1983 May; 130(5):2352-6. PubMed ID: 6339626 [TBL] [Abstract][Full Text] [Related]
7. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein. Mori K; Sakamoto W; Nagasawa S J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579 [TBL] [Abstract][Full Text] [Related]
8. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Berrettini M; Lämmle B; White T; Heeb MJ; Schwarz HP; Zuraw B; Curd J; Griffin JH Blood; 1986 Aug; 68(2):455-62. PubMed ID: 3730610 [TBL] [Abstract][Full Text] [Related]
9. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function. Scott CF; Silver LD; Purdon AD; Colman RW J Biol Chem; 1985 Sep; 260(19):10856-63. PubMed ID: 3875612 [TBL] [Abstract][Full Text] [Related]
10. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen. Kleniewski J; Donaldson VH J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194 [TBL] [Abstract][Full Text] [Related]
11. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen. Nakayasu T; Nagasawa S J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. Kleniewski J; Blankenship DT; Cardin AD; Donaldson V J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355 [TBL] [Abstract][Full Text] [Related]
13. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. Hasan AA; Cines DB; Zhang J; Schmaier AH J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355 [TBL] [Abstract][Full Text] [Related]
14. Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties. Colman RW; Wachtfogel YT; Kucich U; Weinbaum G; Hahn S; Pixley RA; Scott CF; de Agostini A; Burger D; Schapira M Blood; 1985 Feb; 65(2):311-8. PubMed ID: 3871342 [TBL] [Abstract][Full Text] [Related]
15. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein. El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709 [TBL] [Abstract][Full Text] [Related]
16. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. Tayeh MA; Olson ST; Shore JD J Biol Chem; 1994 Jun; 269(23):16318-25. PubMed ID: 8206938 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase. Sato F; Nagasawa S Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488 [TBL] [Abstract][Full Text] [Related]
18. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. Thompson RE; Mandle R; Kaplan AP J Exp Med; 1978 Feb; 147(2):488-99. PubMed ID: 75240 [TBL] [Abstract][Full Text] [Related]
19. Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein. Mashiko H; Miyamoto K; Takahashi H Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):647-56. PubMed ID: 9854812 [TBL] [Abstract][Full Text] [Related]
20. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. Charlesworth MC; Young CY; Miller VM; Tindall DJ J Androl; 1999; 20(2):220-9. PubMed ID: 10232657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]